The proposed bill establishes a psilocybin therapeutic use program in Minnesota for individuals aged 21 and older diagnosed with qualifying medical conditions. It aims to create a legal and regulated framework that prioritizes patient safety, compassionate access, and harm reduction, drawing from the state's medical cannabis program. Key elements include defining the roles of registered patients, designated cultivators, and registered facilitators, as well as forming an advisory committee to assist in rulemaking and program evaluation. The bill outlines eligibility criteria, requiring a written certification from a healthcare practitioner and a health screening, and allows registered patients to cultivate psilocybin for personal use or designate a cultivator.

Additionally, the bill sets regulations for the cultivation and use of psilocybin, mandating that cultivation occurs in a secure location at the primary residence and that use is limited to private properties with consent. Registered facilitators must supervise administration sessions and provide informed consent to patients regarding potential risks. The bill also details the qualifications and registration process for facilitators, ensuring protections against penalties for lawful activities related to psilocybin. It mandates public education on responsible use and harm reduction, establishes a Psychedelic Medicine Advisory Committee, and includes provisions for data privacy and annual fees. Overall, the bill seeks to create a structured and accountable framework for the therapeutic use of psilocybin in Minnesota.